Figure 2.
Subgroup analysis by qSOFA score. (a) The mean serum lactate level in metformin users with qSOFA score ≥2 was significantly higher than that in other groups. Significant difference at p < 0.001 compared with nonusers with qSOFA score ≥2 and nonusers with qSOFA score <2; Significant difference at p = 0.001 compared with metformin users with qSOFA score <2. (b) The mean serum lactate level was significantly higher in metformin users with qSOFA score ≥2 than in metformin users with qSOFA score <2 in both nonsurvivors (p = 0.027) and survivors (p = 0.049). No significant difference was found in nonusers with qSOFA score ≥2 compared with nonusers with qSOFA score <2 in both nonsurvivors (p = 0.584) and survivors (p = 0.756).